Cargando…
Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix
In the present study, we select the Sylysia 350 (Sylysia) as mesoporous material, distearoylphosphatidylethanolamine-poly(ethylene glycol)(2000) (DSPE-PEG) as absorption enhancer and hydroxy propyl methyl cellulose (HPMC) as crystallization inhibitor to prepare sorafenib tosylate (SFN) nanomitrix (M...
Autores principales: | Guo, Yang, Zhong, Ting, Duan, Xiao-Chuan, Zhang, Shuang, Yao, Xin, Yin, Yi-Fan, Huang, Dan, Ren, Wei, Zhang, Qiang, Zhang, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241045/ https://www.ncbi.nlm.nih.gov/pubmed/28165798 http://dx.doi.org/10.1080/10717544.2016.1245371 |
Ejemplares similares
-
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid
por: Li, Zhuo-Yue, et al.
Publicado: (2020) -
Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate
por: Phan, Chi Uyen, et al.
Publicado: (2021) -
Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation
por: Wiergowska, Gabriela, et al.
Publicado: (2021) -
A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1
por: Qu, Wei, et al.
Publicado: (2012) -
Development of Formulation Methods and Physical Characterization of Injectable Sodium Selenite Nanoparticles for the Delivery of Sorafenib tosylate
por: Moni, Sivakumar S., et al.
Publicado: (2020)